Throughout the centuries Slovenia has been invaded from north, south, east and west, but now this small country, only half the size of Switzerland, has gained its independence, joined the European Union and introduced the euro. - All in the last 20 years. 

The rather cautious handling of political and economic reform has allowed for a smooth transformation, which has paid off for the country. As per capita GDP of 17.500 € robust economic growth, modest budget deficits and a stable currency provide an attractive environment both for investors and marketers.

Slovenia's per capita expenditure on pharmaceuticals is clearly highest among Central European countries, whereas imported drugs account for approx. 2/3 of the consumption. The majority of standard preparations enjoy reimbursement at prices not far below European levels. Thus, the small country offers interesting perspectives for foreign companies despite the presence of two major local players.

The regulatory system is harmonised with the EU legislation.